Veradermics (MANE) Reports Q4 Net Loss of $21.8M

2 weeks ago 11

Jeff Lewis

Sun, April 12, 2026 astatine 4:32 PM CDT 1 min read

Veradermics, Incorporated (NYSE:MANE) is 1 of the

8 Healthcare Stocks Insiders Are Buying. On March 30, 2026, Veradermics, Incorporated (NYSE:MANE) reported a Q4 nett nonaccomplishment of $21.8M and ended the twelvemonth with $141.9M successful cash, currency equivalents, and marketable securities. CEO Reid Waldman said 2025 was a “landmark year,” highlighting advancement successful Phase 3 improvement of VDPHL01 and the company’s IPO, portion noting expectations for 2 Phase 3 readouts successful men, continued advancement toward an NDA submission, and advancement of a Phase 3 proceedings for pistillate signifier hairsbreadth loss.

Earlier successful March, Cantor Fitzgerald expert Prakhar Agrawal initiated sum connected Veradermics, Incorporated (NYSE:MANE) with an Overweight rating, noting the company’s absorption connected dermatology and its usage of “validated biology” of minoxidil with optimized pharmacokinetics to amended efficacy and safety.

Veradermics (MANE) Reports Q4 nett nonaccomplishment of $21.8M

Similarly, Leerink initiated sum connected Veradermics, Incorporated (NYSE:MANE) with an Outperform standing and a $75 terms target, highlighting the ample marketplace for hairsbreadth nonaccomplishment treatments and positioning VDPHL01 arsenic a imaginable best-in-class oral therapy for some men and women, supported by a hybrid selling strategy combining telehealth and nonstop access.

Veradermics, Incorporated (NYSE:MANE) develops therapies for dermatologic and aesthetic conditions.

While we admit the imaginable of MANE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article